|
|
Article: Nrf2 essential for efficacy of oltipraz against urinary bladder carcinogenesis.
- Article from:
- Cancer Weekly
- Article date:
- December 21, 2004
CopyrightCOPYRIGHT 2004 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
2004 DEC 21 - (NewsRx.com & NewsRx.net) -- Nrf2 is essential for the efficacy of oltipraz against urinary bladder carcinogenesis.
"The induction of phase 2 detoxifying enzymes, such as UDP-glueuronosyltransferases (UGTs), in response to an array of naturally occurring and synthetic agents, such as oltipraz (4-methyl-5-[2-pyrazinyll-1,2-dithiole-3thione), provides an effective means of protection against a variety of carcinogens.
"Transcription factor Nrf2 is an essential regulator of the inducible expression of detoxifying enzyme genes by chemopreventive agents. In this study, we investigated in Nrf2-deficient mice the susceptibility to the urinary ...